Life Sciences Tools & Services
Price
$197.93
+2.17%Market Cap
$140.09B
Day High
$198.23
Day Low
$194.47
Danaher delivered solid Q1 2026 results with revenue of $5.95B (+3.7% YoY), net income of $1.03B (+7.9% YoY), and diluted EPS of $1.45 (+9.8% YoY), reflecting disciplined cost management and improving profitability despite a slight gross margin compression.
Key risk: Rising Long-Term Debt Load
Long-term debt increased 12.2% YoY to $18.48B, raising leverage concerns in a higher-for-longer interest rate environment. Increased debt service obligations could constrain future capital allocation flexibility, particularly if revenue growth moderates.
Other Life Sciences Tools & Services companies